Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Bile Duct Resection in Major Hepatectomy Due to Intrahepatic Cholangiocarcinoma

NCT01862276 is registered in ClinicalTrials.gov with Kansai Hepatobiliary Oncology Group as lead sponsor.

NCT NCT01862276
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01862276 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Bile Duct Resection in Major Hepatectomy Due to Intrahepatic Cholangiocarcinoma
Lead sponsor
Kansai Hepatobiliary Oncology Group
Phase
Observational
Overall status
Completed
Start date
March 31, 2013
Completion date
March 31, 2014
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

intrahepatic cholangiocarcinoma